GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Capital Expenditure

NeoPharm Co (XKRX:092730) Capital Expenditure : ₩-21,912.90 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

NeoPharm Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-1,218 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-21,912.90 Mil.

NeoPharm Co Capital Expenditure Historical Data

The historical data trend for NeoPharm Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Capital Expenditure Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,798.19 -730.36 -478.12 -806.43 -20,827.99

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -132.97 -585.14 -162.85 -19,947.03 -1,217.88

NeoPharm Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-21,912.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoPharm Co (XKRX:092730) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Capital Expenditure
Comparable Companies
XKRX:234920 XKRX:078520 XKRX:226320 XKRX:317240 XKRX:362320 XKRX:024720 XKRX:256940 XKRX:123690 XKRX:950140 XKRX:214420 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
Website
http://www.neopharm.co.kr
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines